Interventional AI-Human Collaboration for Steatotic Liver Disease Screening

Clinical trial NCT07613827 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07613827
Sponsor: Shengjing Hospital
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

Steatotic Liver Disease Liver Fibrosis Progression in Chronic Liver Disease Liver Steatosis Liver Fibrosis Steatotic Liver Disease of Mixed Origin (MetALD)

Start date: 2026-02-24
Primary completion: 2026-08-30
Enrollment: 7969

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.